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Abstract
Rationale Electrophysiologicalstudieshaveidentifiedascalp
potential,thelatepositivepotential(LPP),whichismodulated
by the emotional intensity of observed stimuli. Previous work
has shown that the LPP reflects the modulation of activity in
extrastriate visual cortical structures, but little is known about
the source of that modulation.
Objectives The present study investigated whether beta-
adrenergic receptors are involvedinthe generationofthe LPP.
Methods We used a genetic individual differences approach
(experiment 1) and a pharmacological manipulation (exper-
iment 2) to test the hypothesis that the LPP is modulated by
the activation of β-adrenergic receptors.
Results In experiment 1, we found that LPP amplitude
depends on allelic variation in the β1-receptor gene
polymorphism. In experiment 2, we found that LPP
amplitude was modulated by the β-blocker propranolol in
a direction dependent on subjects' level of trait anxiety: In
participants with lower trait anxiety, propranolol led to a
(nonsignificant) decrease in the LPP modulation; in
participants with higher trait anxiety, propranolol increased
the emotion-related LPP modulation.
Conclusions These results provide initial support for the
hypothesis that the LPP reflects the downstream effects, in
visual cortical areas, of β-receptor-mediated activation of
the amygdala.
Keywords ERP.Genetic.LPP.Neural basis.
Norepinephrine
A key aspect of emotional stimuli is their emotional
intensity or arousal; the degree to which the stimuli are
pleasant or unpleasant. When participants view stimuli that
vary in emotional arousal, a slow positive-going centropar-
ietal event-related potential (ERP) component can be
recorded at the scalp which begins roughly 400 ms after
stimulus onset and continues until picture offset or even
longer (Foti et al. 2009). The amplitude of this late positive
potential (LPP) increases monotonically with participants'
ratings of their subjective emotional arousal, regardless of
whether the stimuli are experienced as pleasant or unpleas-
ant (Cuthbert et al. 2000; Keil et al. 2002; Lang et al. 1997;
Schupp et al. 2000). Even within the broad categories of
“pleasant,”“ neutral,” and “unpleasant” pictures, the LPP is
larger for more arousing and motivationally salient pictures
(Weinberg and Hajcak 2010). Because of its sensitivity to
emotional arousal, the LPP is increasingly used as a tool for
studying the role of emotion in social behavior (Hurtado et
al. 2009; Ito et al. 1998) and for assessing emotional
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Despite the increasing popularity of the LPP, little is
known about its neural basis. There is a broad consensus
that the LPP reflects the modulation of activity in occipital,
inferotemporal, and parietal visual cortical structures (Keil
et al. 2002; Sabatinelli et al. 2007). However, the source of
this modulation is unclear. Although it remains to be
substantiated, it has been suggested that the LPP modula-
tion may index reentrant feedback from the amygdala to the
visual cortex (Dolcos and Cabeza 2002; Sabatinelli et al.
2007). This hypothesis is consistent with the presence of
direct anatomical projections from the amygdala to the
ventral visual cortex (Amaral et al. 2003; Vuilleumier
2005). It is also consistent with the similar functional
sensitivity of the LPP and amygdala to arousing stimuli;
studies of amygdala activity in monkeys and humans
suggest that, contrary to a widely held view, the amygdala
is just as important for processing pleasant as it is for
processing unpleasant stimuli (Murray 2007). Emotion
regulation manipulations that increase or decrease the
salience of aversive stimuli modulate both amygdala
activity and LPP amplitude (Hajcak et al. 2010).
The enhanced amygdala response to arousing stimuli
involves β-adrenergic receptors. For example, blockage with
a β-adrenergic antagonist, such as propranolol, dampens the
amygdala response to emotional stimuli (Hurlemann et al.
2010; Strange and Dolan 2004; Van Stegeren et al. 2005). β-
adrenergic receptors are sensitive to norepinephrine (NE), a
neuromodulator that is important in the regulation of
emotional arousal (Aston-Jones et al. 1996). Most NE-
containing cells in the human brain are located in a brainstem
nucleus, the locus coeruleus (LC; Berridge and Waterhouse
2003). The LC has extensive connections with the amygdala,
as well as other areas in the brain, and is the only source of
NE to the hippocampus, amygdala, and neocortex. The LC
shows a phasic response to both positive and negative salient
stimuli, during which LC neurons rapidly increase their firing
rates for a short period. As a result, the LC releases more NE
in its projection areas, where β-adrenergic receptors are
activated and temporarily modulate neural activity.
In experiment 1, we used a polymorphism of the β1-
adrenergic receptor to test the hypothesis that activation of
this receptor modulates the LPP. Three subtypes of β-
adrenergic receptors have been identified. These subtypes
are thought to mediate different functions although the
specific functions subserved by each are not fully under-
stood (Berridge and Waterhouse 2003). In the mammalian
brain, most β-receptors are of the β1 subtype (Zill et al.
2003). Evidence from animal studies indicates that this is
also the most abundant subtype in the amygdala (Tiong and
Richardson 1990). The polymorphism we focused on is the
β1-receptor polymorphism G1165C (Borjesson et al. 2000;
Maqbool et al. 1999). The C-allele of this polymorphism is
associated with an enhanced coupling to the stimulatory G
protein and an increased response to the receptor agonists
(Mason et al. 1999). We therefore expected C/C homozy-
gotes to show enhanced LPP amplitudes compared to G/C
heterozygotes and G/G homozygotes. This would provide
initial evidence for the hypothesized β-adrenergic modula-
tion of the LPP.
In experiment 2, we manipulated the activity of β-
adrenergic receptors through the administration of the β-
blocker propranolol and measured the effects on LPP
amplitude. β-receptor blockage with propranolol modulates
the amygdala response to emotional stimuli (Buffalari and
Grace 2007; Strange and Dolan 2004; Van Stegeren et al.
2005). Accordingly, we predicted that β-receptor blockage
would modulate the amplitude of the LPP evoked by
emotional pictures. Because of the strong nonlinear
relationship between baseline noradrenergic activity and
phasic noradrenergic responses (Aston-Jones and Cohen
2005), the effects of noradrenergic drugs on behavioral
(Coull 1994; Hartley et al. 1983; Luksys et al. 2009) and
neural correlates of phasic noradrenergic responses (includ-
ing, as we propose, the LPP) may critically depend on an
individual's natural baseline level of noradrenergic activity.
Therefore, we collected a measure of trait anxiety, which
strongly correlates with baseline noradrenergic activity (Itoi
and Sugimoto 2010; Ressler and Nemeroff 2000), and
examined if the level of trait anxiety interacted with the
effect of treatment.
Materials and methods
Participants Participants in experiment 1 were 28 healthy
students at Leiden University, aged 19–31 years, who
were selected from a database with information on
several polymorphisms related to (nor) adrenergic and
dopaminergic signal transduction. They were paid 10 €
for their participation. We selected 14 subjects who were
homozygous for the C-allele (CC-genotype; seven men;
M age=23.1) and 14 subjects who were either homozy-
gous for the G-allele (GG-genotype) or heterozygous (GC-
genotype; seven men; M age=23.3) for the G1165C
polymorphism in the β1-adrenergic receptor. Data about
other polymorphisms (DBH, ADRB1, ADRB2, NET,
DRD1, DRD2, DRD4, DAT1, COMT, DARPP-32, GNAS,
and BDNF) were not analyzed but is available upon
request from the corresponding author. Informed consent
was obtained from all participants before their inclusion in
the study.
Participants in experiment 2 were 16 healthy young
adults (eight women), aged 18–28 years, who took part in
the experiment in return for 100 €. Only participants with a
972 Psychopharmacology (2012) 219:971–979systolic blood pressure above 100 mmHg, a diastolic blood
pressure above 60 mmHg, and a resting heart rate above 60
beats per minute were included in the study. All participants
in experiment 2 underwent a medical screening, including a
routine physical examination, and were considered to be in
satisfactory health. The use of medication that could
interfere with propranolol was stopped the day before
testing. Participants received an oral dose of 80 mg
propranolol or placebo in a randomized, double-blind,
counterbalanced crossover design. Propranolol and placebo
were administered to each participant on consecutive days
(24 h in between administrations) and in both sessions EEG
was recorded during the performance of a passive viewing
task. The third and final session was 14 (±2) days after the
first session and without any drug or placebo administration
and participants performed a surprise recognition test
(described in detail below). The data from one participant
could not be collected because of severe side effects of
propranolol (de Rover et al. 2010). The study was approved
by the medical ethics committee of the Leiden University
Medical Center and was conducted according to the
Declaration of Helsinki. Informed consent was obtained
from all participants before their inclusion in the study.
Procedure In experiment 2, each participant was tested at
approximately the same time of the day. Drug or placebo was
administered at 9:15–9:45 a.m. and the task started 90 min
afteradministration(10:45–11:15a.m.)becauseofthekinetics
of propranolol's peak plasma concentration (1–2h ) .P a r t i c -
ipants were instructed to abstain from caffeine, nicotine,
alcohol, and other psycho-active substances from 15 h before
the start of the first session until the end of the second
session (the next day). After the medical screening,
participants filled out the Liebowitz Social Anxiety Scale
(LSAS; Liebowitz 1987)
1 and then received a microcrystal-
line cellulose-filled capsule with either propranolol or
placebo (t=0). Propranolol has well-established antihyper-
tensive properties; therefore, blood pressure and heart rate
were monitored for participant safety. Measurements were
taken at t=0, t=60, t=90, t=100, and t=240 min. After
completion of the tasks, the participants were debriefed and
received the financial compensation.
Tasks For experiment 1, we selected 120 pictures from the
International Affective Picture System (IAPS; Lang et al.
2005): 40 highly arousing unpleasant pictures, 40 mildly
arousing unpleasant pictures, and 40 neutral pictures. The
normative valence ratings were: highly unpleasant 2.4,
mildly unpleasant 3.1, and neutral 5.1. The normative
arousal ratings were: highly unpleasant 6.2, mildly unpleas-
ant 5.2, and neutral 2.8 (all ratings were based on a nine-
point scale, Lang 1980). The stimuli were presented in a
random order for 1,000 ms each. Each stimulus presentation
was preceded by a fixation cross for 1,500 ms. Participants
were instructed to view the pictures attentively.
In both sessions of experiment 2, participants were
instructed to passively watch a series of 120 pictures. For the
two sessions (sessions 1 and 2), two different but matched sets
of 120 IAPS pictures were selected. In each set, 40 pictures
depicted unpleasant events (e.g., mutilations, snakes), 40
pleasant events (e.g., sports, erotica), and 40 neutral events
(e.g., houses, faces with a neutral expression). The normative
valence ratings of the two sets of pictures were matched per
picture type (average in sessions 1 and 2, respectively:
unpleasant 2.4 and 2.5; neutral 5.1 and 4.9; pleasant 7.1 and
7.0;effectofsessionF1, 39=0.6,p=0.45; effect of picture type
F2, 78=1,070.7, p<0.001; interaction between session and
picture type F2, 78=1.1, p=0.35). Similarly, the normative
arousal ratings of the two picture sets were matched (in
sessions 1 and 2, respectively, unpleasant 6.2 and 6.2; neutral
2.8 and 2.9; pleasant 5.4 and 5.5; effect of session F1, 39=0.4,
p=0.54; effect of picture type F2, 78=632.2, p<0.001;
interaction between session and picture type: F2, 78=0.2, p=
0.80). The 120 pictures were presented in random order for
1,000 ms each with a 1,500-ms blank screen in between.
Immediately after the passive viewing task, participants
were shown 20 representative pictures from each type that
they had seen in the preceding passive viewing task.
Participants were instructed to rate the subjective arousal
of each picture on a scale from 1 to 4 by pressing a
corresponding button. These data could not be collected
from two participants because of technical problems.
During the third session, 2 weeks after the first session, a
surprise recognition test was administered. In this task,
participants were shown 20 representative pictures of each
picture type from session 1 and 20 from session 2 (not shown
in the rating task) randomly intermixed with an equal number
of new pictures. Participants were instructed to indicate by
buttonpressforeachpicturewhethertheyhadseenitbeforein
one of the sessions (“old”), or whether they had not seen the
picture in one of those sessions (“new”). Some studies have
found that administration of 40 or 80 mg propranolol impairs
encoding (and hence later recognition) of emotional stimuli
(Cahill et al. 1994; Strange et al. 2003; van Stegeren et al.
2008); other studies have failed to replicate this effect
(Strange and Dolan 2004; Tollenaar et al. 2009; Weymar et
al. 2010). If we found a drug effect on recognition
performance, this would provide evidence, in addition to
peripheral drug effects on heart rate, that propranolol affected
central nervous system activity.
1 The Liebowitz Social Anxiety Scale is a trait measure designed to
measuresocialanxiety.Thismeasurewasoriginallyincludedinourstudy
for purposes unrelated to the present report. Importantly, LSAS scores
correlate highly with scores on the Hamilton Anxiety Scale, a more
general measure of trait anxiety (r=0.48 Heimberg et al. 1999; r=0.55
Kummer et al. 2008).
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Ag/AgCl scalp electrodes (Fp1, AFz, Fz, F3, F7, FCz, FC3,
FT7, Cz, C3, T7, CPz, CP3, TP7, Pz, P3, P7, POz, O1, O2,
P8, P4, TP8, CP4, T8, C4, FT8, FC4, F8, F4, Fp2) and
from the left and right mastoids. We measured the
horizontal and vertical electrooculogram using bipolar
recordings from electrodes placed approximately 1 cm
lateral of the outer canthi of the two eyes and from
electrodes placed approximately 1 cm above and below
the participant's right eye.
The EEG signal was pre-amplified at the electrode to
improve the signal-to-noise ratio and amplified with a
gain of 16× by a BioSemi ActiveTwo system (BioSemi
B.V., Amsterdam). The data were digitized at 24-bit
resolution with a sampling rate of 512 Hz using a low-
pass fifth-order sinc filter with a half-power cutoff of
102.4 Hz. Each active electrode was measured online
with respect to a common mode sense active electrode
producing a monopolar (non-differential) channel and
was referenced offline to the average of the left and right
mastoids. Ocular and eye blink artifacts were corrected
using the method of Gratton and colleagues (Gratton et
al. 1983). Epochs with other artifacts (spike artifacts
[50 μV/2 ms] and slow drifts [200 μV/200 ms]) were also
discarded. We extracted single-trial epochs for a period
from 100 ms (experiment 1) or 200 ms (experiment 2)
before until 1,000 ms after stimulus onset. Then, for each
participant and stimulus type (experiment 1 highly
unpleasant, mildly unpleasant, neutral; experiment 2
pleasant, unpleasant, neutral), we averaged the EEG
epochs to create stimulus-locked ERPs. The average
signal during the pre-stimulus baseline was subtracted
from each ERP. LPP amplitude was defined as the average
signal value in a time window from 400–1,000 ms after
stimulus onset at the electrode, where the LPP modulation
manifested its maximum amplitude, CPz in experiment 1
a n dP zi ne x p e r i m e n t2 .
Results
Experiment 1: effect of beta receptor gene polymorphism
on the LPP
Figure 1 displays the grand average waveforms for each
picture type for the β1-receptor genotype groups CC and
GC/GG. As expected, we found a significant effect of
picture type on LPP amplitude (F2, 52=51.1, p<0.001).
Subsequent pairwise comparisons indicated that the order
of the LPP amplitudes mirrored that of the arousal values:
highly unpleasant pictures were associated with a larger
LPP than mildly unpleasant pictures (F1, 26=26.0, p<
0.001), and mildly unpleasant pictures were associated with
a larger LPP than neutral pictures (F1, 26=24.1, p<0.001).
Importantly, there was a significant difference in LPP
amplitude between the two genotype groups (F1, 26=5.2,
p=0.031). As predicted, C/C homozygotes showed en-
hanced LPP amplitudes compared to G/C heterozygotes
and G/G homozygotes. We found no significant interaction
of picture type and β1-receptor genotype (F2, 52=1.2, p=
0.31), reflecting the finding that the effect of genotype was
roughly similar for the three picture types.
Experiment 2: effect of propranolol on the LPP
Cardiovascular measurements Heart rate was used as a
marker to check for successful β-receptor blockade by
propranolol (Fig. 2). Heart rate was registered at baseline,
90 min later, just before the start of the passive viewing task
(pretest), and immediately after the end of the passive
viewing task (posttest). During the experiment, there was a
significant decrease in heart rate (F2, 24=63.2, p<0.001),
which was significantly larger for propranolol than for
placebo treatment (interaction time × treatment F2, 24=26.8,
CPz
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974 Psychopharmacology (2012) 219:971–979p<0.001). Subsequent pairwise comparisons showed that
baseline heart rate did not differ between propranolol and
placebo treatment (t14=1.4, p=0.18), whereas heart rate
was significantly lower in the propranolol condition than
the placebo condition at pretest (t14=3.3, p=0.006) and at
posttest measurements (t14=2.8, p=0.015).
Behavior Consistent with previous studies (Van Stegeren et
al.2005; Weymar et al. 2010; see also Cahill et al. 1995), the
mean rating of the pictures was similar after propranolol and
placebo treatment (Fig. 3a; F1, 12=1.0, p=0.33). The effect
of picture type on rating was significant (F2, 24=58.4,p<
0.001). In line with the normative arousal values,
subsequent pairwise comparisons indicated that unpleas-
ant pictures were rated as more arousing than pleasant
pictures (F1, 12=17.8, p=0.001) and that pleasant pictures
were rated as more arousing than neutral pictures (F1, 12=
78.9, p<0.001). There was no significant interaction
between treatment and picture type (F2, 28=0.5, p=0.62).
Recognition performance did not differ between
placebo and propranolol treatment (Fig. 3b; F1, 14=1.9,
p=0.19). The effect of picture type on recognition
performance was significant (F2, 28=13.8, p<0.001).
Subsequent pairwise comparisons indicated that recogni-
tion performance mirrored the pattern of arousal ratings:
participants recognized more unpleasant pictures than
pleasant pictures (F1, 14=5.4, p=0.036) and more pleasant
pictures than neutral pictures (F1, 14=10.0, p=0.007).
There was no significant interaction between treatment
and picture type (F2, 28=0.9, p=0.42).
Event-related potentials Both pleasant and unpleasant pic-
tureselicitedalargeLPPcomparedtoneutralpictures(Fig.4).
This modulation started around 400 ms and lasted until at
least 1,000 ms after picture onset. Inspection of the scalp
topography maps showed that the modulation was largest at
Pz in both the propranolol and placebo condition. There was
a significant effect of picture type on mean LPP amplitude in
this interval (F2, 28=61.3, p<0.001). Subsequent pairwise
comparisons indicated that the order of the LPP amplitudes
mirrored that of the normative and rated arousal values and
performance on the recognition memory test: unpleasant
pictures were associated with a larger LPP than pleasant
pictures (F1, 14=39.0, p<0.001), and pleasant pictures were
associated with a larger LPP than neutral pictures (F1, 14=
39.7, p<0.001). The LPP amplitude was not affected by
treatment (F1, 14=0.1, p=0.75) and there was no interaction
between picture type and treatment (F2, 28=1.0, p=0.38).
To examine if the main effect of treatment on LPP
amplitude was obscured by a crossover interaction with trait
anxietylevels,werepeatedtheanalysiswhile includingLSAS
score (high or low) as an additional between-subject variable.
LSAS data from one participant were unavailable. The
remaining 14 participants were classified in a high-anxiety
group (N=7, six women; LSAS score M=22.9,SD=9.6)and
low-anxiety group (N=7, one woman; LSAS score M=9.9,
SD=2.7) based on a median split analysis. Anxiety level did
not show a reliable main effect or two-way interactions with
treatment and picture type. Importantly, however, the three
variables showed a significant three-way interaction (F2, 24=
5.6, p=0.01). We investigated this interaction further using
separate ANOVAs for the two anxiety groups. For the low-
anxiety participants, there was no reliable main effect of
treatment (F1, 6=1.2, p=0.31) and no interaction between
treatment and picture type (F2, 12=1.8, p=0.21). For low-
anxious participants (Fig. 5a), propranolol treatment led to
numerically smaller LPPs to pleasant (placebo 3.2 μV,
propranolol 1.7 μV) and unpleasant stimuli (5.1 vs.
3.9 μV), but did not essentially change the LPP to neutral
stimuli (−0.6 vs. −0.8 μV).
In contrast, for the high-anxiety participants, there was
no main effect of treatment (F1, 6=3.4, p=0.11), but there
was a significant interaction between treatment and picture
type (F2, 12=4.3, p=0.040). In the high-anxiety group
(Fig. 5b), propranolol treatment led to numerically larger
LPPs to pleasant (placebo 3.1 μV, propranolol 4.3 μV) and
Fig. 3 Behavioral results
in experiment 2. a Mean sub-
jective arousal ratings for neu-
tral, pleasant, and unpleasant
pictures in the placebo and
propranolol condition. b Aver-
age recognition performance
(hits [% correct old pictures]–
false alarms [% incorrect new
pictures]) for neutral, pleasant,
and unpleasant pictures in the
placebo and propranolol condi-
tion. Error bars indicate stan-
dard errors of the means
Psychopharmacology (2012) 219:971–979 975unpleasant stimuli (5.2 vs. 7.2 μV) and smaller LPPs to
neutral stimuli (1.9 vs. 0.8 μV). Follow-up two-sided t tests
in the high-anxiety group showed a significant treatment
effect on the LPP amplitude associated with unpleasant
pictures (t6=2.7, p=0.038) but not pleasant (p=0.14) and
neutral pictures (p=0.21).
2
Discussion
The LPP holds great promise as a noninvasive neural
measure of emotional arousal in healthy and clinical
populations and offers a temporal resolution that cannot
be achieved with functional magnetic resonance imaging.
However, the neural basis of the LPP is still poorly
understood. Here, we tested the hypothesis that the LPP
reflects the indirect effects, in the visual cortex, of β-
receptor activation in the amygdala. The prediction derived
from that hypothesis is that LPP amplitude should be
dependent on changes in β-receptor activation. The results
presented here provide tentative support for our hypothesis.
In experiment 1, we found that LPP amplitude depended on
individual differences in a β1-receptor gene polymorphism
(G1165C), thus suggesting that the generation of the LPP is
mediated, at least in part, by the activation of β1-receptors.
2 Besides the LPP, we also examined the early posterior negativity
(EPN), defined as the average signal value across electrodes O1 and
O2 in a window from 180 to 250 ms after the stimulus. However, in
experiments 1 and 2, there was no significant effect of genotype or
treatment on EPN amplitude and no significant interaction between
picture type and genotype/treatment.
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976 Psychopharmacology (2012) 219:971–979In experiment 2, we found that LPP amplitude was
modulated by the nonselective beta-blocker propranolol in
a direction dependent on individual differences in trait
anxiety, a marker of baseline noradrenergic activity. These
results leave open the possibility that β2-receptors are also
involved in the generation of the LPP. More research,
including in animal models, is needed to determine the
exact pathways and mechanisms by which β-receptor
activation modulates the LPP at the scalp.
In experiment 1, we found that C/C homozygotes, with
increased sensitivity of the β1-receptor to NE, showed
enhanced LPP amplitudes compared to G/C heterozygotes
and G/G homozygotes. This effect was similar for the three
picture types; it was not specific to the emotionally
arousing pictures. It is important to note that the LPP
elicited by neutral pictures is more than merely a “baseline”
against which the LPP elicited by emotional pictures can be
compared; several studies have found meaningful variation
in the amplitude of the LPP elicited by neutral pictures. For
example, more arousing neutral pictures elicit a larger LPP
(Weinberg and Hajcak 2010) and interfere more with
ongoing behavior (Weinberg and Hajcak 2011) than less-
arousing neutral pictures. This suggests that the LPP is a
continuous measure of arousal and may explain why
increased sensitivity of the β1-receptor to NE is associated
with a greater neural response to all stimuli. Future studies
might further examine whether individuals with the C/C
genotype show increased behavioral interference from
visual distractors independent of picture type.
Previous fMRI studies have found that 40 (Strange and
Dolan 2004) and 80 mg propranolol (Van Stegeren et al.
2005) reliably reduced amygdala activation to emotional
stimuli. In experiment 2, we investigated the effect of
80 mg propranolol on the LPP, which according to our
hypothesis reflects the modulatory control of the amygdala
over the visual cortex. Propranolol treatment did not result
in marked changes in arousal ratings and recognition of the
pictures, but did slow heart rate significantly. The timing of
this heart rate effect indicated that propranolol was effective
while participants were watching the IAPS pictures. In line
with our hypothesis, propranolol modulated LPP amplitude,
but the modulation went in opposite directions, depending
on the participants' trait anxiety—a correlate of baseline
noradrenergic activity. In participants with lower trait
anxiety, propranolol resulted in the predicted (but nonsig-
nificant) decrease in LPP amplitudes associated with
emotional stimuli. In participants with higher trait anxiety,
propranolol significantly enhanced the emotion-related LPP
modulation.
A possible explanation for this interaction between
propranolol and trait anxiety is that propranolol decreases
tonic LC activity through actions at β2-receptors in the LC
(Ampatzis and Dermon 2010; Berridge and Waterhouse
2003). Depending on a subject's baseline level of tonic LC
activity (which correlates with trait anxiety), this shifts the
subject to a higher or lower point on the inverted U curve
describing the strength of phasic LC responses (which
according to our proposal underlie LPP generation) as a
function of tonic LC activity. Subjects with a higher trait
anxiety (right from the center) shift to larger LC responses,
whereas subjects with a lower trait anxiety (center) shift to
smaller LC responses (Fig. 5c). Similar quantitative
interactions have been reported in the dopamine literature:
the effect of dopaminergic drugs on performance in various
types of tasks goes in opposite directions, depending on
trait impulsivity (which correlates with dopamine receptor
binding; Cools et al. 2007) and baseline levels of dopamine
synthesis (Cools et al. 2009).
While we were collecting the data of experiment 2,
Weymar and colleagues (2010) published results that seem
in line with our findings in experiment 2. They used a
parallel-group design to study the effects of propranolol vs.
placebo on ERP correlates of memory for neutral and
emotional IAPS pictures. Although the study focused on
the memory retrieval phase, the authors also reported ERP
waveforms for the encoding phase, which indicated no
effect of propranolol on the LPP. It is possible that the
participants in that study also included a subgroup of
participants with lower trait anxiety in which propranolol
decreased the LPP and a subgroup of participants with
higher trait anxiety in which propranolol increased the LPP.
To our knowledge, the authors did not collect anxiety
measures.
3 Our results suggest that future studies should
more explicitly take into account genotype, personality, and
other individual differences factors that may mediate the
effects of propranolol.
Not only β-receptors but also α2-receptors play a role in
the increased amygdala activation and enhanced memory
associated with emotional stimuli (de Quervain et al. 2007;
Rasch et al. 2009). These receptors, and the polymorphisms
that influence them, may also be important in the generation
of the LPP. Furthermore, there may be other neuromodula-
tory influences on the LPP. For example, it is possible that
the LPP is modulated by the activity of the serotonergic
system, which is known to play an important role in
regulating emotion (Cools et al. 2008). One study has
examined the effects on the LPP of polymorphisms of the
serotonin transporter and tryptophan hydroxylase-2 genes,
3 An interesting aspect of the Weymar et al. (2010) study was that only
male participants were included. It is well established that men
generally report less fear and anxiety than women (McLean and
Anderson 2009), a finding replicated in the LSAS scores of our
participants (men 10.3±1.2; women 22.4±3.8; t12=3.0, p=0.01). This
suggests that the participants in the study of Weymar et al. were
probably more similar to our low-anxiety group.
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2007). Although both polymorphisms affected the EPN, they
were not significantly related to the (early portion of the)
LPP (315–745 ms). Further research is needed to examine if
the LPP is related to other polymorphisms associated with
serotonergic function. Furthermore, the LPP may be modu-
lated by the activity of the dopaminergic system, which is
also known to be involved in the modulation of affect
(Ashby et al. 1999). Franken and colleagues investigated the
effects of dopaminergic drugs on the LPP and found a
nonspecific effect of the D2 agonist bromocriptine on LPP
amplitude (Franken et al. 2008), an effect similar to that of
the beta1-receptor polymorphism in our experiment 1. This
may reflect negative feedback interactions between the
dopaminergic midbrain and the locus coeruleus (Beckstead
et al. 1979). Franken and colleagues found no effect of the
D2 antagonist haloperidol.
Finally, it is worth noting a study that examined the effects
of the selective noradrenergic reuptake inhibitor reboxetine
(4 mg) and the selective serotonergic reuptake inhibitor
citalopram (20 mg) on the LPP to neutral and emotional faces
(Kerestes et al. 2009). This study might have provided
valuable information about neuromodulatory influences on
the LPP. Unfortunately, the study found no effect of facial
expression on the LPP, and therefore also no drug effects.
The absence of an emotion-related LPP modulation was
probably due to the use of happy and sad faces, which in
previous work have also failed to modulate the LPP (in
contrast to threatening faces; e.g., Foti et al. 2010).
In sum, previous work has shown that the LPP reflects
the modulation of activity in extrastriate visual cortical
structures (Keil et al. 2002; Sabatinelli et al. 2007).
However, not much is known about the source of that
modulation. Our results support the hypothesis that one
source of the modulation is the LC-mediated activation of
β-receptors in the amygdala.
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